**** SNAP CHAT MESSENGERS ****

[mick]

Pfizer spends billions to develop new drugs. It’s not satisfied. So it’s launching a startup
By DAMIAN GARDE @damiangarde SEPTEMBER 25, 2017

https://www.statnews.com/2017/09/25/pfizer-startup-new-drugs/

T
here’s a popular theory about the limitations of global pharma companies: For all their skyscrapers and strategy reviews and private jets, they’re simply too knotted up in bureaucracy to realize how many great drugs are gathering dust in their vaults.

Now, the biggest of Big Pharma is out do do something about that. Pfizer, home to nearly 100,000 employees, on Monday announced the launch of a six-person startup to develop new drugs.


More From Other Publishers
How much is Biogen’s spinoff really worth?
STAT
This tech won the Nobel Prize — and drug developers are avidly putting it to use
STAT
5 reasons why no one has built a better EpiPen
STAT
Reporter's notebook: A surge of unexpected optimism around CAR-T
STAT
New drugs, wearable trackers, and a Narcan mask: Ohio tech fund inspires new ideas to fight the opioid crisis
STAT

With deadlines looming, pharma companies look to tighten drug security
STAT
Biotechs anxious as Massachusetts retools growth plan
STAT
The billion-dollar gamble: Biotech CEO takes a risky second shot at an Alzheimer's drug
STAT
Dx Executives Hopeful for Improved Regulation, More Product Development Funding
360Dx, 2016
Potassium Drug Denied Again (Endpoints News)
MedPage Today, 2017